Caprine herpesvirus 1 (CpHV-1) as a potential candidate for oncolytic virotherapy-Reference-Cited by-同舟云学术

Caprine herpesvirus 1 (CpHV-1) as a potential candidate for oncolytic virotherapy

Published:2018-11-08 Issue:1 Volume:20 Page:42-51
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Montagnaro Serena¹^ORCID,Damiano Sara¹,Ciarcia Roberto¹^ORCID,Puzio Maria Valeria¹^ORCID,Ferrara Gianmarco¹,Iovane Valentina²^ORCID,Forte Iris Maria³^ORCID,Giordano Antonio⁴^ORCID,Pagnini Ugo¹^ORCID

Affiliation:

1. Department of Veterinary Medicine and Animal Productions, University of Naples “Federico II”, Napoli, Italia

2. Department of Pharmacy, University of Salerno, Fisciano (Na), Italia

3. OncologyResearch Center of Mercogliano (CROM), Istituto Nazionale Tumori – IRCCS, “Fondazione G. Pascale”, Napoli, Italia

4. Sbarro Institute for Cancer Research and Molecular Medicine, Center of Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2018.1504722

Reference51 articles.

1. Review: Oncolytic virotherapy, updates and future directions

2. Bovine herpesvirus type 1 as a novel oncolytic virus

3. Equine Herpesvirus Type 1-Mediated Oncolysis of Human Glioblastoma Multiforme Cells

4. Oncolytic viruses: a new class of immunotherapy drugs

5. Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cattle exposure to bubaline herpesvirus (BuHV-1) in Southern Italy: A hidden threat for IBR eradication?;Preventive Veterinary Medicine;2024-03

2. Apoptosis is mediated by FeHV-1 through the intrinsic pathway and interacts with the autophagic process;Virology Journal;2023-12-12

3. Autophagy up-regulation upon FeHV-1 infection on permissive cells;Frontiers in Veterinary Science;2023-06-16

4. Preexisting immunity: Barrier or bridge to effective oncolytic virus therapy?;Cytokine & Growth Factor Reviews;2023-04

5. Modifications of the PI3K/Akt/mTOR axis during FeHV-1 infection in permissive cells;Frontiers in Veterinary Science;2023-03-21